
Taeyoon Kim
Examiner (ID: 4325, Phone: (571)272-9041 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651, 1631, 1632 |
| Total Applications | 1176 |
| Issued Applications | 467 |
| Pending Applications | 170 |
| Abandoned Applications | 584 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11992437
[patent_doc_number] => 20170296592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES'
[patent_app_type] => utility
[patent_app_number] => 15/581777
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19155
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581777
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/581777 | CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES | Apr 27, 2017 | Abandoned |
Array
(
[id] => 11992438
[patent_doc_number] => 20170296593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES'
[patent_app_type] => utility
[patent_app_number] => 15/581801
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19155
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581801
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/581801 | CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHOD FOR ISOLATION AND USES | Apr 27, 2017 | Abandoned |
Array
(
[id] => 11864795
[patent_doc_number] => 20170232080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'Treatment of Migraine Headaches with Presynaptic Neurotoxin'
[patent_app_type] => utility
[patent_app_number] => 15/582407
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7411
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15582407
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/582407 | Treatment of migraine headaches with presynaptic neurotoxin | Apr 27, 2017 | Issued |
Array
(
[id] => 16283974
[patent_doc_number] => 20200277576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => METHOD FOR GENERATING INDUCED PLURIPOTENT STEM CELLS FROM FIBROBLAST CELLS
[patent_app_type] => utility
[patent_app_number] => 15/779244
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779244
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/779244 | Method for generating induced pluripotent stem cells from fibroblast cells | Apr 17, 2017 | Issued |
Array
(
[id] => 11755347
[patent_doc_number] => 20170202214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'CRYOPRESERVATION OF CELLS AND SUBCELLULAR FRACTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/478733
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12527
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15478733
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/478733 | CRYOPRESERVATION OF CELLS AND SUBCELLULAR FRACTIONS | Apr 3, 2017 | Abandoned |
Array
(
[id] => 14233395
[patent_doc_number] => 20190128870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => Diagnostic Methods For Patient Specific Therapeutic Decision Making In Cancer Care
[patent_app_type] => utility
[patent_app_number] => 16/091434
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091434
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091434 | Diagnostic Methods For Patient Specific Therapeutic Decision Making In Cancer Care | Apr 3, 2017 | Abandoned |
Array
(
[id] => 14227529
[patent_doc_number] => 20190125937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => Implantable Device for Implantation of Cells Having Anti-Inflammatory and Vascularization Capabilities and Methods of Making Thereof
[patent_app_type] => utility
[patent_app_number] => 16/097138
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097138
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097138 | Implantable Device for Implantation of Cells Having Anti-Inflammatory and Vascularization Capabilities and Methods of Making Thereof | Apr 3, 2017 | Abandoned |
Array
(
[id] => 11954776
[patent_doc_number] => 20170258927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'FORMULATIONS AND DOSES OF PEGYLATED URICASE'
[patent_app_type] => utility
[patent_app_number] => 15/456520
[patent_app_country] => US
[patent_app_date] => 2017-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 31073
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15456520
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/456520 | FORMULATIONS AND DOSES OF PEGYLATED URICASE | Mar 10, 2017 | Abandoned |
Array
(
[id] => 13871357
[patent_doc_number] => 20190032019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => METHOD FOR MANUFACTURING CULTURE PRODUCT LIQUID
[patent_app_type] => utility
[patent_app_number] => 16/073352
[patent_app_country] => US
[patent_app_date] => 2017-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 586
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073352
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073352 | METHOD FOR MANUFACTURING CULTURE PRODUCT LIQUID | Mar 8, 2017 | Abandoned |
Array
(
[id] => 11949701
[patent_doc_number] => 20170253852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'Method of Fermenting Mycelium Composite Material'
[patent_app_type] => utility
[patent_app_number] => 15/450198
[patent_app_country] => US
[patent_app_date] => 2017-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1645
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15450198
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/450198 | Method of fermenting mycelium composite material | Mar 5, 2017 | Issued |
Array
(
[id] => 16785264
[patent_doc_number] => 10987669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Apparatus and method for detection of tumour cells and circulating tumour cells
[patent_app_type] => utility
[patent_app_number] => 16/081720
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18109
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081720
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081720 | Apparatus and method for detection of tumour cells and circulating tumour cells | Mar 2, 2017 | Issued |
Array
(
[id] => 13982417
[patent_doc_number] => 20190060366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => HIGHLY ENGRAFTABLE HEMATOPOIETIC STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/080264
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16080264
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/080264 | HIGHLY ENGRAFTABLE HEMATOPOIETIC STEM CELLS | Feb 26, 2017 | Abandoned |
Array
(
[id] => 13827089
[patent_doc_number] => 20190017029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => Generation of Expandable Cardiovascular Progenitor Cells
[patent_app_type] => utility
[patent_app_number] => 16/076824
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076824 | Generation of Expandable Cardiovascular Progenitor Cells | Feb 23, 2017 | Abandoned |
Array
(
[id] => 11668349
[patent_doc_number] => 20170157069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'COMPOSITION USING METFORMIN FOR PREVENTING OR TREATING IMMUNE DISEASES INCLUDING LUPUS'
[patent_app_type] => utility
[patent_app_number] => 15/440738
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7982
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440738
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440738 | COMPOSITION USING METFORMIN FOR PREVENTING OR TREATING IMMUNE DISEASES INCLUDING LUPUS | Feb 22, 2017 | Abandoned |
Array
(
[id] => 12117289
[patent_doc_number] => 20180000875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'PROBIOTICS FOR USE IN REDUCING THE INCIDENCE AND DURATION OF ILLNESS'
[patent_app_type] => utility
[patent_app_number] => 15/434376
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10244
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15434376
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/434376 | PROBIOTICS FOR USE IN REDUCING THE INCIDENCE AND DURATION OF ILLNESS | Feb 15, 2017 | Abandoned |
Array
(
[id] => 14454613
[patent_doc_number] => 10323259
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => Formulation and process for biohydrogen production
[patent_app_type] => utility
[patent_app_number] => 15/426815
[patent_app_country] => US
[patent_app_date] => 2017-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 6544
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15426815
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/426815 | Formulation and process for biohydrogen production | Feb 6, 2017 | Issued |
Array
(
[id] => 14291999
[patent_doc_number] => 10286108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Irreversible electroporation to create tissue scaffolds
[patent_app_type] => utility
[patent_app_number] => 15/423986
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 9826
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15423986
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/423986 | Irreversible electroporation to create tissue scaffolds | Feb 2, 2017 | Issued |
Array
(
[id] => 14243991
[patent_doc_number] => 10272178
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Methods for blood-brain barrier disruption using electrical energy
[patent_app_type] => utility
[patent_app_number] => 15/424335
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 11995
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15424335
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/424335 | Methods for blood-brain barrier disruption using electrical energy | Feb 2, 2017 | Issued |
Array
(
[id] => 12707668
[patent_doc_number] => 20180127722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => COMPOSITION FOR TREATING TENDONITIS AND MANUFACTURE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/416502
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15416502
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/416502 | COMPOSITION FOR TREATING TENDONITIS AND MANUFACTURE THEREOF | Jan 25, 2017 | Abandoned |
Array
(
[id] => 13824135
[patent_doc_number] => 20190015552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => Vascular Extracellular Matrix Hydrogel
[patent_app_type] => utility
[patent_app_number] => 16/070044
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16070044
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/070044 | Vascular extracellular matrix hydrogel | Jan 12, 2017 | Issued |